These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35806183)

  • 21. Prion disease detection, PMCA kinetics, and IgG in urine from sheep naturally/experimentally infected with scrapie and deer with preclinical/clinical chronic wasting disease.
    Rubenstein R; Chang B; Gray P; Piltch M; Bulgin MS; Sorensen-Melson S; Miller MW
    J Virol; 2011 Sep; 85(17):9031-8. PubMed ID: 21715495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia.
    Das S; Goossens J; Jacobs D; Dewit N; Pijnenburg YAL; In 't Veld SGJG; Teunissen CE; Vanmechelen E
    Alzheimers Res Ther; 2023 Mar; 15(1):62. PubMed ID: 36964594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnetic microparticle-based multimer detection system for the detection of prion oligomers in sheep.
    Lim K; Kim SY; Lee B; Segarra C; Kang S; Ju Y; Schmerr MJ; Coste J; Kim SY; Yokoyama T; An SS
    Int J Nanomedicine; 2015; 10(Spec Iss):241-50. PubMed ID: 26425091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Review: Fluid biomarkers in the human prion diseases.
    Thompson AGB; Mead SH
    Mol Cell Neurosci; 2019 Jun; 97():81-92. PubMed ID: 30529227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
    Thompson AGB; Anastasiadis P; Druyeh R; Whitworth I; Nayak A; Nihat A; Mok TH; Rudge P; Wadsworth JDF; Rohrer J; Schott JM; Heslegrave A; Zetterberg H; Collinge J; Jackson GS; Mead S
    Mol Psychiatry; 2021 Oct; 26(10):5955-5966. PubMed ID: 33674752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
    Kern S; Syrjanen JA; Blennow K; Zetterberg H; Skoog I; Waern M; Hagen CE; van Harten AC; Knopman DS; Jack CR; Petersen RC; Mielke MM
    JAMA Neurol; 2019 Feb; 76(2):187-193. PubMed ID: 30419087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinctive Toll-like Receptors Gene Expression and Glial Response in Different Brain Regions of Natural Scrapie.
    García-Martínez M; Cortez LM; Otero A; Betancor M; Serrano-Pérez B; Bolea R; Badiola JJ; Garza MC
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
    Falgàs N; Ruiz-Peris M; Pérez-Millan A; Sala-Llonch R; Antonell A; Balasa M; Borrego-Écija S; Ramos-Campoy O; Augé JM; Castellví M; Tort-Merino A; Olives J; Fernández-Villullas G; Blennow K; Zetterberg H; Bargalló N; Lladó A; Sánchez-Valle R
    Hum Brain Mapp; 2020 Jun; 41(8):2004-2013. PubMed ID: 31944489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Quantification of CSF Biomarkers in Antibody-Mediated Encephalitis.
    Day GS; Yarbrough MY; Körtvelyessy P; Prüss H; Bucelli RC; Fritzler MJ; Mason W; Tang-Wai DF; Steriade C; Hébert J; Henson RL; Herries EM; Ladenson JH; Lopez-Chiriboga AS; Graff-Radford NR; Morris JC; Fagan A
    Neurology; 2021 May; 96(20):e2546-e2557. PubMed ID: 33795390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BAMBI and CHGA in Prion Diseases: Neuropathological Assessment and Potential Role as Disease Biomarkers.
    López-Pérez Ó; Bernal-Martín M; Hernaiz A; Llorens F; Betancor M; Otero A; Toivonen JM; Zaragoza P; Zerr I; Badiola JJ; Bolea R; Martín-Burriel I
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32370154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
    Lukkarinen H; Tesseur I; Pemberton D; Van Der Ark P; Timmers M; Slemmon R; Janssens L; Streffer J; Van Nueten L; Bottelbergs A; Rauramaa T; Koivisto AM; Herukka SK; Korhonen VE; Junkkari A; Hiltunen M; Engelborghs S; Blennow K; Zetterberg H; Kolb HC; Leinonen V
    J Alzheimers Dis; 2021; 80(4):1629-1642. PubMed ID: 33720890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurofilament light chain in central nervous system infections: a prospective study of diagnostic accuracy.
    van Zeggeren IE; Ter Horst L; Heijst H; Teunissen CE; van de Beek D; Brouwer MC
    Sci Rep; 2022 Aug; 12(1):14140. PubMed ID: 35986031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
    Mok TH; Nihat A; Majbour N; Sequeira D; Holm-Mercer L; Coysh T; Darwent L; Batchelor M; Groveman BR; Orr CD; Hughson AG; Heslegrave A; Laban R; Veleva E; Paterson RW; Keshavan A; Schott JM; Swift IJ; Heller C; Rohrer JD; Gerhard A; Butler C; Rowe JB; Masellis M; Chapman M; Lunn MP; Bieschke J; Jackson GS; Zetterberg H; Caughey B; Rudge P; Collinge J; Mead S
    Brain; 2023 Jun; 146(6):2570-2583. PubMed ID: 36975162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic and prognostic value of CSF neurofilaments in a cohort of patients with motor neuron disease: A cross-sectional study.
    Gagliardi D; Faravelli I; Meneri M; Saccomanno D; Govoni A; Magri F; Ricci G; Siciliano G; Pietro Comi G; Corti S
    J Cell Mol Med; 2021 Apr; 25(8):3765-3771. PubMed ID: 33609080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
    Bloniecki V; Zetterberg H; Aarsland D; Vannini P; Kvartsberg H; Winblad B; Blennow K; Freund-Levi Y
    Alzheimers Res Ther; 2020 Nov; 12(1):153. PubMed ID: 33203439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid immunological biomarkers associated with axonal damage in multiple sclerosis.
    Villar LM; Picón C; Costa-Frossard L; Alenda R; García-Caldentey J; Espiño M; Muriel A; Álvarez-Cermeño JC
    Eur J Neurol; 2015 Aug; 22(8):1169-75. PubMed ID: 25324032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of neurofilament light chain in the cerebrospinal fluid and blood as a biomarker for neuronal damage in experimental pneumococcal meningitis.
    Le ND; Muri L; Grandgirard D; Kuhle J; Leppert D; Leib SL
    J Neuroinflammation; 2020 Oct; 17(1):293. PubMed ID: 33028339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
    Zerr I; Schmitz M; Karch A; Villar-Piqué A; Kanata E; Golanska E; Díaz-Lucena D; Karsanidou A; Hermann P; Knipper T; Goebel S; Varges D; Sklaviadis T; Sikorska B; Liberski PP; Santana I; Ferrer I; Zetterberg H; Blennow K; Calero O; Calero M; Ladogana A; Sánchez-Valle R; Baldeiras I; Llorens F
    Alzheimers Dement; 2018 Jun; 14(6):751-763. PubMed ID: 29391125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
    Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
    J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal serum neurofilament light chain concentrations in sheep inoculated with the agent of classical scrapie.
    Brown Q; Nicholson E; Wang C; Greenlee J; Seger H; Veneziano S; Cassmann E
    PLoS One; 2024; 19(2):e0299038. PubMed ID: 38394122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.